PREventing Pain After Surgery
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Mar 23, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "PREventing Pain After Surgery" is exploring a new way to help patients manage pain after back surgery. It focuses on a brief therapy called Acceptance and Commitment Therapy (ACT), which aims to prevent long-lasting pain and reduce the need for opioid pain medications after surgery. The study will check how well this therapy works, how easy it is for patients to take part in, and whether it can help people avoid developing chronic pain six months after their lumbar spine surgery.
To participate in this trial, you need to be at least 22 years old, fluent in English, and scheduled for certain types of spine surgeries, such as fusion or discectomy. It's important to know that this study is not for individuals with severe cognitive issues, those who are pregnant, or anyone who has had significant spinal problems or previous spinal surgeries. If you join, you can expect to receive the ACT intervention and share your experiences, which will help researchers understand its effectiveness and how it can best support patients like you in managing pain after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • scheduled to undergo fusion, discectomy, vertebroplasty, kyphoplasty, or foraminotomy
- • age 22 and older
- • able to communicate fluently in English
- Exclusion Criteria:
- • inability to complete study procedures due to delirium, dementia, psychosis, or other cognitive impairment
- • have a history of severe neurologic movement disorder
- • are pregnant or intent to become pregnant during study
- • have undergone previous spinal surgery
- • have spinal deformity, pseudarthrosis, trauma, infection, or tumor as primary indication for surgery
- • have undergone Acceptance and Commitment Therapy in last 2 years
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chestnut Hill, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials